Z. Ortiz et al., The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials, J RHEUMATOL, 26(1), 1999, pp. 210-216
To review the available evidence that has used generic instruments alone or
in comparison with disease specific instruments. A systematic review was c
arried out using the methods recommended by the Cochrane Collaboration. We
used MEDLINE and EMBASE searches and we performed a hand search of the abst
racts listed under "quality of life" at American College of Rheumatology (A
CR) meetings. Selection was limited to randomized controlled trials (RCT) u
sing generic instruments in populations older than 18 years with any of the
following diseases: rheumatoid arthritis, fibromyalgia, osteoporosis, oste
oarthritis, systemic lupus erythematosus, and ankylosing spondylitis. Langu
age was restricted to English papers. Studies using only disease-specific i
nstruments were excluded. From 488 articles retrieved, 13 reports of 10 ran
domized controlled trials were selected. There were 101 abstracts on qualit
y of life in ACR abstract books; 78 abstracts contained data on generic ins
truments, and of these, 9 described their use in RCT. Despite a substantial
increase in the number of papers and abstracts addressing different aspect
s of generic questionnaires, the majority of the papers were descriptive. T
he evidence is not yet available to document that any of the generic instru
ments pass the requirements of the OMERACT Filter.